U.S. market Closed. Opens in 43 minutes

SNSE | Sensei Biotherapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue571.00K1.81M685.00K209.00K73.00KN/A
Gross Profit-571.00K-1.81M-685.00K-209.00K-73.00KN/A
Operating Expenses37.06M50.19M37.48M18.71M12.44M12.74M
Selling, General & Admin18.66M19.80M15.82M7.53M4.08M4.51M
Research & Development18.30M30.38M21.66M11.19M8.35M8.23M
Other Operating Expenses100.00K1.60M688.00K-649.00K-1.00K28.00K
Operating Income-37.06M-50.19M-37.48M-19.45M-12.44M-12.74M
Other Expenses / Income2.96M1.60M688.00K-649.00K-4.30M28.00K
Before Tax Income-34.10M-48.59M-36.79M-20.10M-16.74M-13.04M
Income Tax Expenses100.00K219.00K670.00K529.00K2.25M299.00K
Net Income-34.10M-48.81M-37.46M-20.63M-19.00M-13.04M
Interest Expenses144.00K219.00K670.00K1.69M2.26M327.00K
Basic Shares Outstanding27.95M30.70M27.71M30.59M29.33M685.16K
Diluted Shares Outstanding27.95M30.70M27.71M30.59M29.33M685.16K
EBITDA-35.61M-50.19M-36.00M-17.98M-12.36M-12.67M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-33.86M-48.37M-36.12M-18.41M-14.48M-12.41M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙